Erratum to ‘Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC’ [JTO Clinical and Research Reports Volume 6 Issue 5 (2025) 100815]
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | JTO Clinical and Research Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666364325000591 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850090797503873024 |
|---|---|
| author | Federico Cappuzzo, MD Zanete Zvirbule, MD Ernesto Korbenfeld, MD Jaroslaw Kolb-Sielecki, MD Dolores Isla, MD, PhD Aleksandra Szczesna, MD, PhD Amparo Yovanna Castro Sanchez, PhD Alberto Bustillos, MD Xiaoyan Liu, PhD Fiona Young, MbChB Nadia Tosti, PhD Marta Freitas Monteiro, MSc, PhD Margarita Majem, MD, PhD |
| author_facet | Federico Cappuzzo, MD Zanete Zvirbule, MD Ernesto Korbenfeld, MD Jaroslaw Kolb-Sielecki, MD Dolores Isla, MD, PhD Aleksandra Szczesna, MD, PhD Amparo Yovanna Castro Sanchez, PhD Alberto Bustillos, MD Xiaoyan Liu, PhD Fiona Young, MbChB Nadia Tosti, PhD Marta Freitas Monteiro, MSc, PhD Margarita Majem, MD, PhD |
| author_sort | Federico Cappuzzo, MD |
| collection | DOAJ |
| format | Article |
| id | doaj-art-fdaf449124d1411082cfad8bb76aad98 |
| institution | DOAJ |
| issn | 2666-3643 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Elsevier |
| record_format | Article |
| series | JTO Clinical and Research Reports |
| spelling | doaj-art-fdaf449124d1411082cfad8bb76aad982025-08-20T02:42:29ZengElsevierJTO Clinical and Research Reports2666-36432025-07-016710084210.1016/j.jtocrr.2025.100842Erratum to ‘Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC’ [JTO Clinical and Research Reports Volume 6 Issue 5 (2025) 100815]Federico Cappuzzo, MD0Zanete Zvirbule, MD1Ernesto Korbenfeld, MD2Jaroslaw Kolb-Sielecki, MD3Dolores Isla, MD, PhD4Aleksandra Szczesna, MD, PhD5Amparo Yovanna Castro Sanchez, PhD6Alberto Bustillos, MD7Xiaoyan Liu, PhD8Fiona Young, MbChB9Nadia Tosti, PhD10Marta Freitas Monteiro, MSc, PhD11Margarita Majem, MD, PhD12IRCCS Regina Elena National Cancer Institute, Rome, Italy; Corresponding author: Federico CappuzzoRiga Eastern Clinical University Hospital, Riga, LatviaHospital Británico de Buenos Aires, Buenos Aires, ArgentinaWarmian-Masurian Center of Pulmonary Diseases, Olsztyn, PolandUniversity Hospital Lozano Blesa, Zaragoza, IIS Aragon, SpainMazowieckie Centrum Leczenia Chorób Płuc Gruźlicy, Otwock, PolandF. Hoffmann-La Roche Ltd., Basel, SwitzerlandF. Hoffmann-La Roche Ltd., Basel, SwitzerlandGenentech, Inc., South San Francisco, CaliforniaF. Hoffmann-La Roche Ltd., Welwyn Garden City, United KingdomF. Hoffmann-La Roche Ltd., Basel, SwitzerlandF. Hoffmann-La Roche Ltd., Basel, SwitzerlandHospital de la Santa Creu i Sant Pau, Barcelona, Spainhttp://www.sciencedirect.com/science/article/pii/S2666364325000591 |
| spellingShingle | Federico Cappuzzo, MD Zanete Zvirbule, MD Ernesto Korbenfeld, MD Jaroslaw Kolb-Sielecki, MD Dolores Isla, MD, PhD Aleksandra Szczesna, MD, PhD Amparo Yovanna Castro Sanchez, PhD Alberto Bustillos, MD Xiaoyan Liu, PhD Fiona Young, MbChB Nadia Tosti, PhD Marta Freitas Monteiro, MSc, PhD Margarita Majem, MD, PhD Erratum to ‘Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC’ [JTO Clinical and Research Reports Volume 6 Issue 5 (2025) 100815] JTO Clinical and Research Reports |
| title | Erratum to ‘Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC’ [JTO Clinical and Research Reports Volume 6 Issue 5 (2025) 100815] |
| title_full | Erratum to ‘Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC’ [JTO Clinical and Research Reports Volume 6 Issue 5 (2025) 100815] |
| title_fullStr | Erratum to ‘Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC’ [JTO Clinical and Research Reports Volume 6 Issue 5 (2025) 100815] |
| title_full_unstemmed | Erratum to ‘Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC’ [JTO Clinical and Research Reports Volume 6 Issue 5 (2025) 100815] |
| title_short | Erratum to ‘Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC’ [JTO Clinical and Research Reports Volume 6 Issue 5 (2025) 100815] |
| title_sort | erratum to primary results from imscin002 a study to evaluate patient preferences and perceptions of health care professionals for atezolizumab subcutaneous versus intravenous for the treatment of nsclc jto clinical and research reports volume 6 issue 5 2025 100815 |
| url | http://www.sciencedirect.com/science/article/pii/S2666364325000591 |
| work_keys_str_mv | AT federicocappuzzomd erratumtoprimaryresultsfromimscin002astudytoevaluatepatientpreferencesandperceptionsofhealthcareprofessionalsforatezolizumabsubcutaneousversusintravenousforthetreatmentofnsclcjtoclinicalandresearchreportsvolume6issue52025100815 AT zanetezvirbulemd erratumtoprimaryresultsfromimscin002astudytoevaluatepatientpreferencesandperceptionsofhealthcareprofessionalsforatezolizumabsubcutaneousversusintravenousforthetreatmentofnsclcjtoclinicalandresearchreportsvolume6issue52025100815 AT ernestokorbenfeldmd erratumtoprimaryresultsfromimscin002astudytoevaluatepatientpreferencesandperceptionsofhealthcareprofessionalsforatezolizumabsubcutaneousversusintravenousforthetreatmentofnsclcjtoclinicalandresearchreportsvolume6issue52025100815 AT jaroslawkolbsieleckimd erratumtoprimaryresultsfromimscin002astudytoevaluatepatientpreferencesandperceptionsofhealthcareprofessionalsforatezolizumabsubcutaneousversusintravenousforthetreatmentofnsclcjtoclinicalandresearchreportsvolume6issue52025100815 AT doloresislamdphd erratumtoprimaryresultsfromimscin002astudytoevaluatepatientpreferencesandperceptionsofhealthcareprofessionalsforatezolizumabsubcutaneousversusintravenousforthetreatmentofnsclcjtoclinicalandresearchreportsvolume6issue52025100815 AT aleksandraszczesnamdphd erratumtoprimaryresultsfromimscin002astudytoevaluatepatientpreferencesandperceptionsofhealthcareprofessionalsforatezolizumabsubcutaneousversusintravenousforthetreatmentofnsclcjtoclinicalandresearchreportsvolume6issue52025100815 AT amparoyovannacastrosanchezphd erratumtoprimaryresultsfromimscin002astudytoevaluatepatientpreferencesandperceptionsofhealthcareprofessionalsforatezolizumabsubcutaneousversusintravenousforthetreatmentofnsclcjtoclinicalandresearchreportsvolume6issue52025100815 AT albertobustillosmd erratumtoprimaryresultsfromimscin002astudytoevaluatepatientpreferencesandperceptionsofhealthcareprofessionalsforatezolizumabsubcutaneousversusintravenousforthetreatmentofnsclcjtoclinicalandresearchreportsvolume6issue52025100815 AT xiaoyanliuphd erratumtoprimaryresultsfromimscin002astudytoevaluatepatientpreferencesandperceptionsofhealthcareprofessionalsforatezolizumabsubcutaneousversusintravenousforthetreatmentofnsclcjtoclinicalandresearchreportsvolume6issue52025100815 AT fionayoungmbchb erratumtoprimaryresultsfromimscin002astudytoevaluatepatientpreferencesandperceptionsofhealthcareprofessionalsforatezolizumabsubcutaneousversusintravenousforthetreatmentofnsclcjtoclinicalandresearchreportsvolume6issue52025100815 AT nadiatostiphd erratumtoprimaryresultsfromimscin002astudytoevaluatepatientpreferencesandperceptionsofhealthcareprofessionalsforatezolizumabsubcutaneousversusintravenousforthetreatmentofnsclcjtoclinicalandresearchreportsvolume6issue52025100815 AT martafreitasmonteiromscphd erratumtoprimaryresultsfromimscin002astudytoevaluatepatientpreferencesandperceptionsofhealthcareprofessionalsforatezolizumabsubcutaneousversusintravenousforthetreatmentofnsclcjtoclinicalandresearchreportsvolume6issue52025100815 AT margaritamajemmdphd erratumtoprimaryresultsfromimscin002astudytoevaluatepatientpreferencesandperceptionsofhealthcareprofessionalsforatezolizumabsubcutaneousversusintravenousforthetreatmentofnsclcjtoclinicalandresearchreportsvolume6issue52025100815 |